title: What next when metformin isn't enough for type 2 diabetes?
abstract: This patient-centered case vignette offers insight into how best to choose among additional oral agents, basal insulin, or the newer GLP-1 receptor agonists.
authors.affiliation: University of North Carolina School of Medicine, Chapel Hill, NC, USA.
authors.forename: Emily M
authors.initials: EM
authors.lastname: Hawes
authors.affiliation: University of North Carolina School of Medicine, Chapel Hill, NC, USA.
authors.forename: Joseph
authors.initials: J
authors.lastname: Wehby
authors.affiliation: University of North Carolina School of Medicine, Chapel Hill, NC, USA. Email:anne_mounsey@med.unc.edu.
authors.forename: Anne
authors.initials: A
authors.lastname: Mounsey
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000145:classification / Q000494:pharmacology; D054539:Medication Therapy Management; D008687:Metformin / Q000494:pharmacology*; D017410:Practice Guidelines as Topic
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D008687:Metformin